Press "Enter" to skip to content

Cipla completes successful phase-3 clinical study of generic asthma drug

The Phase-3 study, which successfully completed in the first attempt, was conducted over a period of 15 months at over 100 sites in the US enrolling 1,400 asthma patients, it added.

Leave your comments

%d bloggers like this: